Implementation of a survivorship care plan for cancer patients
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
NA · Indiana University · NCT05346796
This study tests whether an online care plan can help colorectal cancer survivors manage their health better and follow important check-up guidelines.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Indiana University (other) |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT05346796 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of an interactive survivorship care plan delivered through an Internet-based personal health record for colorectal cancer survivors. It combines a randomized clinical effectiveness trial with a mixed methods implementation study to assess how well the survivorship care plan meets the long-term care needs of patients. The study aims to improve adherence to surveillance and preventive care guidelines while addressing unmet symptom needs through tailored self-management tools. By engaging patients in their own care, the trial seeks to enhance overall health outcomes for colorectal cancer survivors.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with Stage I, II, or III colorectal cancer and have completed initial curative treatment within the past year.
Not a fit: Patients with recurrent colorectal cancer, severe cognitive impairment, or those currently in hospice care may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the long-term care and quality of life for colorectal cancer survivors.
How similar studies have performed: Other studies have shown promise in using personalized health records to improve patient engagement and care outcomes, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients must be 18 years or older at the time of consent 2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend). 3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months. 4. English-speaking Exclusion Criteria: 1. Patient will be excluded if they have had recurrence of their colorectal cancer. 2. Patient's with severe cognitive impairment 3. Patient's with schizophrenia or other psychosis 4. Patients currently in hospice care
Where this trial is running
Indianapolis, Indiana
- Indiana University School of Medicine — Indianapolis, Indiana, United States (RECRUITING)
Study contacts
- Study coordinator: David A Haggstrom, MD
- Email: dahaggst@iu.edu
- Phone: (317) 274-9000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer